Kimia Farma Persero Tbk (JK:KAEF) — Market Cap & Net Worth
Market Cap & Net Worth: Kimia Farma Persero Tbk (KAEF)
Kimia Farma Persero Tbk (JK:KAEF) has a market capitalization of $144.17 Million (Rp2.46 Trillion) as of September 18, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #17885 globally and #282 in its home market, demonstrating a -9.43% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Kimia Farma Persero Tbk's stock price Rp442.00 by its total outstanding shares 5566588406 (5.57 Billion). Also see total assets of Kimia Farma Persero Tbk for a full breakdown of the balance sheet.
Kimia Farma Persero Tbk Market Cap History: 2015 to 2026
Kimia Farma Persero Tbk's market capitalization history from 2015 to 2026. Data shows change from $274.09 Million to $144.17 Million (-6.01% CAGR). Also see KAEF cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
Kimia Farma Persero Tbk is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Jakarta Stock Exchange Composite Index
JKSE
|
$504.33 Billion | 0.03% | #275 of 864 |
Weight: Kimia Farma Persero Tbk's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Kimia Farma Persero Tbk Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Kimia Farma Persero Tbk's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Kimia Farma Persero Tbk (KAEF) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
Kimia Farma Persero Tbk's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $872.23 Million | $5.81 Trillion | $267.41 Billion | 0.00x | 0.00x |
| 2017 | $859.75 Million | $6.13 Trillion | $326.79 Billion | 0.00x | 0.00x |
| 2018 | $834.42 Million | $7.45 Trillion | $415.90 Billion | 0.00x | 0.00x |
| 2019 | $403.06 Million | $9.40 Trillion | -$12.72 Billion | 0.00x | N/A |
| 2020 | $1.37 Billion | $10.01 Trillion | $17.64 Billion | 0.00x | 0.08x |
| 2021 | $783.93 Million | $12.86 Trillion | $302.27 Billion | 0.00x | 0.00x |
| 2022 | $353.91 Million | $9.23 Trillion | -$190.47 Billion | 0.00x | N/A |
| 2023 | $471.33 Million | $9.97 Trillion | -$1.49 Trillion | 0.00x | N/A |
| 2024 | $197.34 Million | $9.94 Trillion | -$842.27 Billion | 0.00x | N/A |
| 2025 | $167.98 Million | $9.22 Trillion | -$334.96 Billion | 0.00x | N/A |
Competitor Companies of KAEF by Market Capitalization
Companies near Kimia Farma Persero Tbk in the global market cap rankings as of September 18, 2026. Review Kimia Farma Persero Tbk tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Kimia Farma Persero Tbk by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #249 globally with a market cap of $101.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #542 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #642 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1221 globally with a market cap of $21.15 Billion USD ( AU$29.90 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #249 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $887.29 |
| #542 | Cencora Inc. | NYSE:COR | $50.53 Billion | $318.50 |
| #642 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $232.54 |
| #1221 | Sigma Healthcare Ltd | AU:SIG | $21.15 Billion | AU$2.59 |
Kimia Farma Persero Tbk Historical Marketcap From 2015 to 2026
Between 2015 and today, Kimia Farma Persero Tbk's market cap moved from $274.09 Million to $ 144.17 Million, with a yearly change of -6.01%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp144.17 Million | -14.17% |
| 2025 | Rp167.98 Million | -14.88% |
| 2024 | Rp197.34 Million | -58.13% |
| 2023 | Rp471.33 Million | +33.18% |
| 2022 | Rp353.91 Million | -54.86% |
| 2021 | Rp783.93 Million | -42.80% |
| 2020 | Rp1.37 Billion | +240.00% |
| 2019 | Rp403.06 Million | -51.70% |
| 2018 | Rp834.42 Million | -2.95% |
| 2017 | Rp859.75 Million | -1.43% |
| 2016 | Rp872.23 Million | +218.23% |
| 2015 | Rp274.09 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Kimia Farma Persero Tbk was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $144.17 Million USD |
| MoneyControl | $144.17 Million USD |
| MarketWatch | $144.17 Million USD |
| marketcap.company | $144.17 Million USD |
| Reuters | $144.17 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Kimia Farma Persero Tbk
PT Kimia Farma Tbk, together with its subsidiaries, manufactures and sells a range of medicines in Indonesia and internationally. It operates through Manufacture, Distribution, Retail, and Others segments. The company offers drugs in the form of tablets, effervescent tablets, hard and soft capsules, liquids, syrups, oral powders, non-beta-lactam external liquids, beta-lactam tablets and dry syrup… Read more